RecruitingPhase 4NCT07136714

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Studying Mal de débarquement

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nordsjaellands Hospital
Principal Investigator
Maj Vinberg, MD, PhD, DMSc
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Intervention
Semaglutide Injectable Product(drug)
Enrollment
116 target
Eligibility
18-65 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07136714 on ClinicalTrials.gov

Other trials for Mal de débarquement

Additional recruiting or active studies for the same condition.

See all trials for Mal de débarquement

← Back to all trials